Coastal Investment Advisors, Inc. Tandem Diabetes Care Inc Transaction History

Coastal Investment Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 23, 2020	SELL	$95.43 - $116.09 $2.42 Million - $2.95 Million	-25,397 Closed	0 $0
Q2 2020 Jul 16, 2020	SELL	$60.05 - $98.92 $35,249 - $58,066	-587 Reduced 2.26%	25,397 $2.51 Million
Q1 2020 Apr 23, 2020	SELL	$47.37 - $90.04 $29,558 - $56,184	-624 Reduced 2.35%	25,984 $1.67 Million
Q4 2019 Feb 05, 2020	BUY	$53.13 - $71.19 $18,276 - $24,489	344 Added 1.31%	26,608 $1.83 Million
Q3 2019 Oct 18, 2019	BUY	$57.11 - $73.3 $357,508 - $458,858	6,260 Added 31.29%	26,264 $1.55 Million
Q2 2019 Aug 01, 2019	BUY	$54.41 - $71.7 $169,106 - $222,843	3,108 Added 18.39%	20,004 $1.29 Million
Q1 2019 May 15, 2019	BUY	$32.25 - $73.56 $544,896 - $1.24 Million	16,896 New	16,896 $1.08 Million

359

72.2M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.37B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.